Clinical Trials Browser

Interventional × Castrate Resistant Prostate Cancer × Clear all

NCT01907009 2023-04-19

MEL-CAP

Phase 2/3 Terminated

Castrate Resistant Prostate Cancer

NCT01352208 2014-03-24

Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

Phase 1/2 Terminated

Castrate Resistant Prostate Cancer